Stereotactic Lung Irradiation in Mice Promotes Long-Term Senescence and Lung Injury

Int J Radiat Oncol Biol Phys. 2020 Apr 1;106(5):1017-1027. doi: 10.1016/j.ijrobp.2019.12.039. Epub 2020 Jan 25.

Abstract

Purpose: Lung cancer will be treated more frequently using stereotactic body radiation therapy, and preclinical research to model long-term toxicity of ablative doses of radiation is crucial. Stereotactic lung irradiation of a small volume can induce radiation pneumonitis and fibrosis in normal tissues.

Methods and materials: Senescence has been reported to contribute to lung fibrosis, and we investigated in vivo the effects of ablative doses of ionizing radiation on senescence-associated processes. The left lung of p16INK4a-LUC knock-in mice was exposed to a single dose or fractionated radiation doses in a millimetric volume using a small animal radiation research platform.

Results: Single or fractionated ablative radiation induces acute and very long-term p16INK4a activation in the irradiated lung target volume associated with lung injury. We observed a panel of heterogeneous senescent cells including pneumocytes, macrophages, and endothelial cells that accumulated around the radiation-induced lung focal lesion, suggesting that different senescent cell types may contribute to radiation injury.

Conclusions: This work provides important information on the long-term effects of ablative radiation doses in the normal lung and strongly suggests that stress-induced senescence is involved in stereotactic body radiation therapy-induced late fibrosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cellular Senescence / radiation effects*
  • Cyclin-Dependent Kinase Inhibitor p16 / metabolism
  • Dose-Response Relationship, Radiation
  • Endothelial Cells / pathology
  • Endothelial Cells / radiation effects
  • Lung Injury / diagnostic imaging
  • Lung Injury / etiology
  • Lung Injury / metabolism
  • Lung Injury / pathology*
  • Mice
  • Tomography, X-Ray Computed

Substances

  • Cyclin-Dependent Kinase Inhibitor p16